Literature DB >> 10437237

116 cases of coronary angina pectoris treated with powder composed of radix ginseng, radix notoginseng and succinum.

J Yuan1, W Guo, B Yang, P Liu, Q Wang, H Yuan.   

Abstract

116 cases of coronary angina pectoris were treated with a powder composed of Radix Ginseng, Radix Notoginseng and Succinum, which was an empirical prescription of Dr. Yue Meizhong ([symbol: see text]), and compared with patients treated Fufang Danshen Tablet (a compound prescription of Radix Salviae Miltiorrhizae) as the control group. Results indicated that the curative effects and ECG in the treated group were better than that in the control group (P < 0.01), so were improvement of general symptoms, physical strength as well as changes of lipid metabolism and microcirculation of nail fold.

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 10437237

Source DB:  PubMed          Journal:  J Tradit Chin Med        ISSN： 0255-2922            Impact factor:   0.848


  7 in total

Review 1.  Roles and mechanisms of ginseng in protecting heart.

Authors:  Si-Dao Zheng; Hong-Jin Wu; De-Lin Wu
Journal:  Chin J Integr Med       Date:  2012-07-07       Impact factor: 1.978

Review 2.  Therapeutic potential of ginseng in the management of cardiovascular disorders.

Authors:  Morris Karmazyn; Melissa Moey; Xiaohong Tracey Gan
Journal:  Drugs       Date:  2011-10-22       Impact factor: 9.546

Review 3.  Panax ginseng: a systematic review of adverse effects and drug interactions.

Authors:  Joanna Thompson Coon; Edzard Ernst
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Red ginseng extract facilitates the early differentiation of human embryonic stem cells into mesendoderm lineage.

Authors:  Yoon Young Kim; Seung-Yup Ku; Zev Rosenwaks; Hung Ching Liu; Sun Kyung Oh; Shin Yong Moon; Young Min Choi
Journal:  Evid Based Complement Alternat Med       Date:  2010-09-01       Impact factor: 2.629

5.  Saponin accumulation in the seedling root of Panax notoginseng.

Authors:  Dong Wang; Hongtao Zhu; Keke Chen; Min Xu; Yingjun Zhang; Chongren Yang
Journal:  Chin Med       Date:  2011-01-24       Impact factor: 5.455

Review 6.  Pharmacological and medical applications of Panax ginseng and ginsenosides: a review for use in cardiovascular diseases.

Authors:  Jong-Hoon Kim
Journal:  J Ginseng Res       Date:  2017-10-21       Impact factor: 6.060

7.  Randomized, double-blind, placebo-controlled phase I dose escalation study of Dan Qi Tong Mai tablet in healthy volunteers.

Authors:  Zhong-Ping Gou; Wei Zhang; Xiu-Fang Liang; Ying Wang; Ju-Hong Mou; Mei Li; Ya Zhang; Ping Feng
Journal:  BMC Complement Altern Med       Date:  2019-11-27       Impact factor: 3.659
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.